ContraFect Appoints CMO
This article was originally published in Scrip
Executive Summary
Dr Cara Cassino is joining ContraFect Corporation, a clinical-stage biotech company focused on the discovery and development of protein therapeutics and antibody products, as chief medical officer. Most recently, Cassino held the position of senior vice president, global clinical development at Forest Laboratories Inc (acquired by Actavis plc, now Allergan plc) and served on its R&D executive leadership team.